Novartis’ recent dual clinical…
Novartis’ recent dual clinical setbacks have prompted questions from a [...]
The FDA has put enrollment in…
The FDA has put enrollment in trials of Biohaven’s epilepsy [...]
Frazier Life Sciences (FLS) has…
Frazier Life Sciences (FLS) has stacked up another sizable biotech-focused [...]
Andy Plump, M.D., Ph.D., president…
Andy Plump, M.D., Ph.D., president of research and development at [...]
It may have seemed like an…
It may have seemed like an ordinary Wednesday afternoon at [...]
A New Drug Lifts the Fog of Sleepiness for Those With Narcolepsy
The first-of-its-kind drug offers a reprieve for people who live [...]
With a phase 3 win now fleshed out…
With a phase 3 win now fleshed out and an [...]
Merck continues sweeping staff…
Merck continues sweeping staff reductions, laying off 54 at its [...]
Luma Group announced the final…
Luma Group announced the final close of its inaugural life [...]
Neuro-focused Encoded Therapeutics…
Neuro-focused Encoded Therapeutics has bagged a $275 million series F [...]